OncoGenex Regains Rights to Custirsen from Teva

Go back to OncoGenex Regains Rights to Custirsen from Teva
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $2.80 
Open $0.05    52 Week Low $0.33 
Day High $0.40    P/E N/A 
Day Low $0.40    EPS $-1.98 
Volume 500       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 41.38 +0.66 (1.62%)
Previous Close $40.72    52 Week High $66.55 
Open $41.30    52 Week Low $37.82 
Day High $41.85    P/E N/A 
Day Low $41.03    EPS $0.00 
Volume 5,666,303       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 41.38 +0.66 (1.62%)
Previous Close $40.72    52 Week High $66.55 
Open $41.30    52 Week Low $37.82 
Day High $41.85    P/E N/A 
Day Low $41.03    EPS $0.00 
Volume 5,666,303